Prilosec Articles
New York Stock Comment
30 May 1997
Astra Gains Three More Losec Patents
26 May 1997
Pylorid Vs Omeprazole For HP Eradication
19 May 1997
European And London Stock Comment
5 May 1997
Shock Growth Slowdown At Sweden's Astra
23 April 1997
Short-Term Outlook Good For Astra
21 April 1997
Rhone-Poulenc Reorganizes In India
7 April 1997
Glaxo Wellcome 1996 Product Performance
17 March 1997
US Rx Wholesale Prices "Up 1.8% In 1996"
3 March 1997
Europe Stock Comment
3 March 1997
Pharma Strategies: M&A Or Technical Excellence?
3 March 1997
Currency Exchange Affects 1996 Sales At Astra
24 February 1997
US Rx Drug Sales For 1996 Up 10% At $85.35 Billion
24 February 1997
US Sales Of Astra's Prilosec Up 40% In 1996
10 February 1997
Glaxo Wellcome Breaches IFPMA Marketing Code
3 February 1997
US Sales Of Astra's Prilosec Up 40% In 1996
31 January 1997
US 4th Qtr/Year-End Results See Strong Growth
27 January 1997
Zocor "Will Be World's Top-Selling Drug In 2005"
13 January 1997
Astra's Losec "World's No One Drug In 1998-2000"
16 December 1996
Astra Remains Strong In First Nine Months Of 96
11 November 1996
Portuguese Firm Sues Astra For Damages
4 November 1996
Triple Therapy For H Pylori
28 October 1996
Searle Reports Progress With COX-2 Inhibitor
21 October 1996
H Pylori Vaccine Sparks Speculation In Ulcer Market
14 October 1996
IF Cantabria Starts Polemic On Prices In Spain
23 September 1996
Foreign Drug Firms Will Bear Burden Of Juppe Plan
16 September 1996
Progress For Cortecs In Fiscal 1996
9 September 1996
P&G To Launch Low-Cost Helicobacter Regimen In USA
2 September 1996
Boots Buy Boosts BASF In 1996 First Half
2 September 1996
Currency-Related Distortions Hit Astra
2 September 1996
7% Pretax Profits Growth For Astra
19 August 1996
Glaxo Wellcome's Tritec Cleared In USA
19 August 1996
Global Branding Is A Must For Pharmaceuticals
12 August 1996
Patent Expiries Set To Drive Generics Boom
22 July 1996
Astra Lodges Complaint Against Portugal
15 July 1996
ChemTrak Gets US Appro for H pylori kit
8 July 1996
Byk Gulden Forecasts Pantoprazole Sales
24 June 1996
Astra And Byk Gulden End PPI Dispute
17 June 1996
Glaxo Wellcome Shares Undervalued, Say Analysts
17 June 1996
World Pharma Market Growth 11.6% In 1995
27 May 1996
Astra As Expected In First Quarter
20 May 1996
Omeprazole Sales Soar 57% In The USA
22 April 1996
...And Astra Sues Byk Competitors In France
22 April 1996
1st H pylori Treatment Approved In USA
22 April 1996
EUROPE STOCK COMMENT
22 April 1996
Astra Cuts Price Of Losec In Sweden
15 April 1996
Dutch Proposed Maximum Drug Prices Published
8 April 1996
Prilosec Approved For Gastric Ulcers In USA
1 April 1996
Corporate Ranking - A New Order For 1995
1 April 1996
World Pharma Sales Up 11.6% In 1995, Says PMSI
18 March 1996
Sweden's Pharma Market Expanded 12.7% In 1995
4 March 1996
Astra's Losec-Fueled Growth Continues In 1995
26 February 1996
Losec "Will Be The World's Top-Selling Drug In 2000"
26 February 1996
ChemTrak's H pylori Test
12 February 1996
European Stock Markets Review 1995
22 January 1996
All Change For Top Drugs In Year 2000: Lehman Bros
15 January 1996
EU Iberian P-I Ruling And The Dutch Market
8 January 1996
Ulcer Therapy Market Set For Transformation
18 December 1995
Astra Merck Gets Bucindolol Rights
18 December 1995
Astra, Et Al Fighting A Patent War In Portugal
4 December 1995
Astra Strengthens R&D With Increased Spending
4 December 1995
EUROPE STOCK COMMENT
20 November 1995
Astra Building Prioritized Therapeutic Areas
20 November 1995
33% Sales Growth For Astra
13 November 1995
Byk Gulden gets Astra writ for omeprazole infringement
6 November 1995
Swedish Pharma Market Jan-Sept 1995
6 November 1995
Brazil: Dynamic Growth For Antiulcerants
6 November 1995
EUROPEAN STOCK COMMENT
23 October 1995
Astra AB: Nycomed AB pantoprazole injunction
2 October 1995
"Only H pylori And NSAIDs Cause Ulcers"
25 September 1995
Glaxo Wellcome's Pylorid Launched In First Market
18 September 1995
France's Pharma Market Set To Grow 6.3% PA To 2000
18 September 1995
PPIs Boost Euro Peptic Ulcer Drug Sales
4 September 1995
Astra Posts Strong Growth Slightly Ahead Of Forecasts
4 September 1995
European Stock Comment
31 July 1995
Glaxo's Zantac Losing Market Share In USA
31 July 1995
US Sales of Generic Drugs Up 29% In 1994, Says IMS
17 July 1995
European stock comment
10 July 1995
Merck pipline report
3 July 1995
Prilosec: Maintenance Use Approved In USA
3 July 1995
Good Performance Forecast For Euro Drugmakers
26 June 1995
The ABPI's A-Z Of British Medicines Research
29 May 1995
Fujisawa Net Down Though Operating Income Soars
29 May 1995
Outstanding 1st Qtr Performance For Astra
22 May 1995
proton pump inhibitor vs H2 antagonists
22 May 1995
Disease ManagementThe Way Forward
15 May 1995
Modern Triple Therapy For H Pylori
8 May 1995
Losec Europe's Top-Selling Product
10 April 1995
Astra Files Suit Against Byk Gulden
3 April 1995
Rulid For Helicobacter Eradication
3 April 1995
20 Leading US Drugs' Price Increases Slammed
27 March 1995
FDA Clears New Labelling For Prilosec
20 March 1995
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
